[January 09, 2013]

Research and Markets: Throat Cancer - Pipeline Review, H2 2012 Contains a Snapshot of the Global Therapeutic Scenario for Throat Cancer

Research and Markets (http://www.researchandmarkets.com/research/g889w4/throat_cancer) has announced the addition of Global Markets Direct's new report "Throat Cancer - Pipeline Review, H2 2012" to their offering.

Global Markets Direct's, 'Throat Cancer - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Throat Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Throat Cancer. Throat Cancer - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC (News - Alert) filings, investor presentations and featured press releases fom company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- A review of the Throat Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Throat Cancer pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Companies Mentioned:

- F. Hoffmann-La Roche Ltd.

- Sanofi-Aventis

- YM BioSciences Inc.

- Cyclacel Pharmaceuticals Inc.

- Advaxis, Inc.

- Prima BioMed Limited

- Jiangsu Hengrui Medicine Co., Ltd.

- Biotech Pharmaceuticals Co., Ltd.

For more information visit http://www.researchandmarkets.com/research/g889w4/throat_cancer

Source (News - Alert): Global Markets Directp

[ Back To TMCnet.com's Homepage ]